Cargando…

Altered mental status in a case of multiple myeloma not related to a metabolic cause

Detalles Bibliográficos
Autores principales:	Sandhu, Gagangeet, Farias, Antony A., Ranade, Aditi, Meisels, Ira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421399/ https://www.ncbi.nlm.nih.gov/pubmed/25949373 http://dx.doi.org/10.1093/ndtplus/sfp083

Ejemplares similares

Delayed spontaneous resolution of nephrotic syndrome in a patient with hepatitis C virus-associated membranoproliferative glomerulonephritis
por: Sandhu, Gagangeet, et al.
Publicado: (2010)

Diffuse alveolar haemorrhage in ANCA-negative pauci-immune crescentic glomerulonephritis
por: Sandhu, Gagangeet, et al.
Publicado: (2010)

Blue toe syndrome as a clue to the underlying cause of acute renal failure
por: Sandhu, Gagangeet, et al.
Publicado: (2010)

Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma
por: Ludwig, C, et al.
Publicado: (2015)

Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma
por: Rizzieri, Dustin, et al.
Publicado: (2019)

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients
por: Ke, Mengying, et al.
Publicado: (2021)

Multiple Myeloma: An Unexpected Cause of Dysphagia After Cervical Spine Surgery
por: Chen, Chang Jun, et al.
Publicado: (2023)

Managing multiple myeloma
por: Lee, Ann S., et al.
Publicado: (2021)

Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma
por: Han, Lu, et al.
Publicado: (2021)

Renal Papillary Necrosis Caused by Protein C Deficiency Leading to Recurrent Hydronephrosis
por: Chugh, Rohit Kumar, et al.
Publicado: (2016)

Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance
por: Weir, Philip, et al.
Publicado: (2023)

Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)

Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma
por: Zajec, Marina, et al.
Publicado: (2020)

Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2018)

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
por: Markus, Efrat, et al.
Publicado: (2020)

Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes
por: Fairfield, Heather, et al.
Publicado: (2021)

Carbamazepine and Multiple Myeloma: Possible Interaction
por: Günaldı, Meral, et al.
Publicado: (2013)

Daratumumab in dialysis-dependent multiple myeloma
por: Jeyaraman, Preethi, et al.
Publicado: (2020)

Metabolic Features of Multiple Myeloma
por: El Arfani, Chaima, et al.
Publicado: (2018)

Metabolic Disorders in Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Metabolic Vulnerabilities in Multiple Myeloma
por: Lim, Julia S. L., et al.
Publicado: (2022)

Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018)

Osteoarthrosis causing altered mental status: a case report
por: Reddy, Yogesh N V, et al.
Publicado: (2014)

Hypercalcemia-Induced Hypokalemic Metabolic Alkalosis in a Multiple Myeloma Patient: The Risk of Furosemide Use
por: Reiser, Ira W., et al.
Publicado: (2015)

Multiple Myeloma Causing Gastric Polyposis
por: Hammad, Tariq, et al.
Publicado: (2017)

Lack of Ku80 Alteration in Multiple Myeloma
por: Kato, Miyuki, et al.
Publicado: (2002)

Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)

Multiple myeloma presenting with focal segmental glomerulosclerosis
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Oligosecretory multiple myeloma: a case report
por: Khurana, Ujjawal, et al.
Publicado: (2016)

The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019)

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma
por: Modi, Dipenkumar, et al.
Publicado: (2015)

An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome
por: Kandemir Alibakan, Özlem, et al.
Publicado: (2020)

Renal cell carcinoma concomitant with multiple myeloma
por: Narwal, Anubhav, et al.
Publicado: (2022)

Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)

Consolidation in multiple myeloma – current status and perspectives
por: Olszewska-Szopa, Magdalena, et al.
Publicado: (2014)

Oral health status of patients with multiple myeloma
por: Feitosa, Édila Figuerêdo, et al.
Publicado: (2020)

Metabolic Volume Measurements in Multiple Myeloma
por: Takahashi, Maria Emilia Seren, et al.
Publicado: (2021)

Lipid metabolic vulnerabilities of multiple myeloma
por: Torcasio, Roberta, et al.
Publicado: (2023)

Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma
por: Bennink, M. Christine, et al.
Publicado: (2022)

High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center Study
por: Bennink, Christine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oe25jq02h30fao9b83on8h48jb